SCHEMBL2812834

SCHEMBL2812834

CC(=CSc1ccccc1)C(=O)Nc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.53
NAPRT Q6XQN6 1/20 0.53
MAPT P10636 7/20 0.47
RAB9A P51151 5/20 0.47
NPC1 O15118 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 3/20 0.47
TAAR1 Q96RJ0 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
EPHX1 P07099 2/20 0.45
GAA P10253 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 2/20 0.44
MAPK1 P28482 2/20 0.44
TP53 P04637 2/20 0.44
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812831 1.00 HSD17B10 (0.53) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2810262 0.91 NAPRT (0.47) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2812064 0.91 ALDH1A1 (0.50) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2810265 0.91 NAPRT (0.47) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2812062 0.91 ALDH1A1 (0.50) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2809174 0.90 RAB9A (0.47) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2809170 0.90 RAB9A (0.47) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2807280 0.90 RAB9A (0.47) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2807273 0.90 RAB9A (0.47) HSD17B10NAPRTMAPTRAB9ANPC1
SCHEMBL2811224 0.87 EGFR (0.49) MAPTRAB9ANPC1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101808986-B Imidate compound and use thereof for pest control SUMITOMO CHEMICAL CO 2013-10-02 CN disclosed
US-8318981-B2 Imidate compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-11-27 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100210683-A1 IMIDATE COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-08-19 US disclosed
CN-101808986-A Imidate compound and use thereof for pest control SUMITOMO CHEMICAL CO 2010-08-18 CN disclosed
EP-2183215-A2 IMIDATE COMPOUND AND USE THEREOF FOR PEST CONTROL Sumitomo Chemical Company, Limited (JP) 2010-05-12 EP disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009014267-A2 IMIDATE COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 HSD17B10 1243/4885NAPRT 3883/4885MAPT 4608/4885
US-20100210683-A1 IMIDATE COMPOUND AND USE THEREOF FOR PEST CONTROL CYP1A1, CYC1, C1S HSD17B10 612/4885NAPRT 3975/4885MAPT 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.